CHMX · As filed with the SEC
NEXT-ChemX income statement, by fiscal year
The statement as NEXT-ChemX presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Statement of Operations · USD, except per-share amounts
| USD, except per-share amounts | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 |
|---|---|---|---|
| Operating expenses | |||
| Selling, General and Administrative Expense | — | 1,976,601 | 1,673,284 |
| Total Costs and Expenses | 760,954 | — | — |
| Professional Fees | 732,676 | — | — |
| Depreciation Expense | 155,118 | — | — |
| Other operating Expenses | 86,151 | — | — |
| Total operating expenses | 1,734,899 | 1,976,601 | 1,673,284 |
| Income (loss) from operations | (1,734,899) | (1,976,601) | (1,673,284) |
| Other income (expense) | |||
| Interest expense | — | (87,682) | (70,515) |
| Interest expense | (186,700) | — | — |
| Other income (expense) | 107,273 | (296,948) | — |
| Net other expense | (79,427) | (384,630) | (70,515) |
| Income Before Tax | (1,814,326) | (2,361,231) | (1,743,799) |
| Net income (loss) | (1,814,326) | (2,361,231) | (1,743,799) |
| Earnings Per Share (Basic) | (0.06) | (0.08) | (0.06) |
| Earnings Per Share (Diluted) | (0.06) | (0.08) | (0.06) |
| Weighted Average Shares Outstanding | 28,546,834 | 28,466,560 | 27,802,153 |
| Weighted Average Shares Outstanding, Diluted | 28,546,834 | 28,466,560 | 27,802,153 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.